Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study.

Maze, Dawn; Arcasoy, Murat O; Henrie, Ryan; Cerquozzi, Sonia; Kamble, Rammurti; Al-Hadidi, Samer; Yacoub, Abdulraheem; Singh, Anurag K; Elsawy, Mahmoud; Sirhan, Shireen; Smith, Elliot; Marcoux, Curtis; Viswabandya, Auro; Daly, Andrew; Sibai, Hassan; McNamara, Caroline; Shi, Yuliang; Xu, Wei; Lajkosz, Katherine; Foltz, Lynda; Gupta, Vikas

Maze, Dawn; Arcasoy, Murat O; Henrie, Ryan; Cerquozzi, Sonia; Kamble, Rammurti; Al-Hadidi, Samer; Yacoub, Abdulraheem; Singh, Anurag K; Elsawy, Mahmoud; Sirhan, Shireen; Smith, Elliot; Marcoux, Curtis; Viswabandya, Auro; Daly, Andrew; Sibai, Hassan; McNamara, Caroline; Shi, Yuliang; Xu, Wei; Lajkosz, Katherine; Foltz, Lynda; Gupta, Vikas.

Affiliation

Maze D; The Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada. dawn.maze@uhn.ca.
Arcasoy MO; Duke Cancer Institute, Duke University School of Medicine, Durham, NC, USA.
Henrie R; Division of Hematology, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.
Cerquozzi S; Tom Baker Cancer Centre, Alberta Health Service Calgary Zone, University of Calgary, Calgary, AB, Canada.
Kamble R; Center for Cell and Gene Therapy, Baylor College of Medicine and Houston Methodist Hospital, Houston, TX, USA.
Al-Hadidi S; Myeloma Section, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Yacoub A; Division of Hematology and Oncology, University of Kansas Medical Center, Kansas City, KS, USA.
Singh AK; Division of Hematology and Oncology, University of Kansas Medical Center, Kansas City, KS, USA.
Elsawy M; Division of Hematology, Dalhousie University, Halifax, NS, Canada.
Sirhan S; Jewish General Hospital, McGill University, Montreal, QC, Canada.
Smith E; The Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
Marcoux C; Division of Hematology, Dalhousie University, Halifax, NS, Canada.
Viswabandya A; The Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
Daly A; Tom Baker Cancer Centre, Alberta Health Service Calgary Zone, University of Calgary, Calgary, AB, Canada.
Sibai H; The Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
McNamara C; The Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
Shi Y; Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Xu W; Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, ON, Canada.
Lajkosz K; Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Foltz L; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Gupta V; Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.

Bone Marrow Transplant ; 59(2): 196-202, 2024 02.

Article de En | MEDLINE | ID: mdl-37938736

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Transplantation de cellules souches hématopoïétiques / Myélofibrose primitive / Inhibiteurs des Janus kinases Limites: Humans Pays/Région comme sujet: America do norte Langue: En Journal: Bone Marrow Transplant Sujet du journal: TRANSPLANTE Année: 2024 Type de document: Article Pays d'affiliation: Canada

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google